209 related articles for article (PubMed ID: 38695960)
1.
Boschi A; Urso L; Uccelli L; Martini P; Filippi L
EJNMMI Radiopharm Chem; 2024 May; 9(1):36. PubMed ID: 38695960
[TBL] [Abstract][Full Text] [Related]
2. Design and Development of
Lindner T; Altmann A; Krämer S; Kleist C; Loktev A; Kratochwil C; Giesel F; Mier W; Marme F; Debus J; Haberkorn U
J Nucl Med; 2020 Oct; 61(10):1507-1513. PubMed ID: 32169911
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Preliminary Study of
Ma M; Yang G; Zhao M; Liu Y; Ge X; Jia B; Gao S
Mol Pharm; 2024 Feb; 21(2):735-744. PubMed ID: 38193393
[TBL] [Abstract][Full Text] [Related]
4. Preparation and Bioevaluation of
Ruan Q; Feng J; Jiang Y; Zhang X; Duan X; Wang Q; Yin G; Xiao D; Zhang J
Mol Pharm; 2022 Jan; 19(1):160-171. PubMed ID: 34904839
[TBL] [Abstract][Full Text] [Related]
5. A Simple Kit Formulation for Preparation and Exploratory Human Studies of a Novel
Ruan Q; Zhou C; Wang Q; Kang F; Jiang Y; Li G; Feng J; Zong S; Zhang J; Wang J
Mol Pharm; 2023 Jun; 20(6):2942-2950. PubMed ID: 37083360
[TBL] [Abstract][Full Text] [Related]
6. SPECT Imaging with Tc-99m-Labeled HYNIC-FAPI-04 to Extend the Differential Time Window in Evaluating Tumor Fibrosis.
Luo X; Zhang Z; Cheng C; Wang T; Fang D; Zuo C; Yuan G; Li R; Li X
Pharmaceuticals (Basel); 2023 Mar; 16(3):. PubMed ID: 36986521
[TBL] [Abstract][Full Text] [Related]
7. A novel molecular imaging probe [
Jiang Y; Tian Y; Feng B; Zhao T; Du L; Yu X; Zhao Q
Sci Rep; 2023 Mar; 13(1):3700. PubMed ID: 36879039
[TBL] [Abstract][Full Text] [Related]
8. Targeting Fibroblast Activation Protein: Radiosynthesis and Preclinical Evaluation of an
Toms J; Kogler J; Maschauer S; Daniel C; Schmidkonz C; Kuwert T; Prante O
J Nucl Med; 2020 Dec; 61(12):1806-1813. PubMed ID: 32332144
[TBL] [Abstract][Full Text] [Related]
9. Formulation and Preclinical Testing of Tc-99m-Labeled HYNIC-Glc-FAPT as a FAP-Targeting Tumor Radiotracer.
Yang X; Li G; Ruan C; Hu K; Tang G
Bioconjug Chem; 2023 Nov; 34(11):2133-2143. PubMed ID: 37874952
[TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis and Preclinical Assessment of
Trujillo-Benítez D; Luna-Gutiérrez M; Ferro-Flores G; Ocampo-García B; Santos-Cuevas C; Bravo-Villegas G; Morales-Ávila E; Cruz-Nova P; Díaz-Nieto L; García-Quiroz J; Azorín-Vega E; Rosato A; Meléndez-Alafort L
Molecules; 2022 Jan; 27(1):. PubMed ID: 35011496
[TBL] [Abstract][Full Text] [Related]
11.
Liu Y; Zhang Q; Zhang Y; Wang J; Wu Y; Yang G; Shi J; Wang F; Xu Z; Jing H
Pharmaceuticals (Basel); 2023 Oct; 16(10):. PubMed ID: 37895905
[TBL] [Abstract][Full Text] [Related]
12.
Lindner T; Altmann A; Giesel F; Kratochwil C; Kleist C; Krämer S; Mier W; Cardinale J; Kauczor HU; Jäger D; Debus J; Haberkorn U
EJNMMI Radiopharm Chem; 2021 Aug; 6(1):26. PubMed ID: 34417894
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and preclinical evaluation of novel
Zhou H; Zhong J; Peng S; Liu Y; Tang P; Cai Z; Wang L; Xu H; Hu K
Eur J Med Chem; 2024 Jan; 264():115993. PubMed ID: 38039792
[TBL] [Abstract][Full Text] [Related]
14. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
15. A radiohybrid theranostics ligand labeled with fluorine-18 and lutetium-177 for fibroblast activation protein-targeted imaging and radionuclide therapy.
Yang T; Peng L; Qiu J; He X; Zhang D; Wu R; Liu J; Zhang X; Zha Z
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2331-2341. PubMed ID: 36864362
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive imaging of FAP expression using positron emission tomography: A comparative evaluation of a [
Huang J; Fu L; Zhang X; Huang S; Dong Y; Hu K; Han Y; Zhou K; Min C; Huang Y; Tang G
Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3363-3374. PubMed ID: 37266596
[TBL] [Abstract][Full Text] [Related]
17. IDH-wildtype glioblastomas and grade III/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein-specific PET/CT.
Röhrich M; Loktev A; Wefers AK; Altmann A; Paech D; Adeberg S; Windisch P; Hielscher T; Flechsig P; Floca R; Leitz D; Schuster JP; Huber PE; Debus J; von Deimling A; Lindner T; Haberkorn U
Eur J Nucl Med Mol Imaging; 2019 Nov; 46(12):2569-2580. PubMed ID: 31388723
[TBL] [Abstract][Full Text] [Related]
18. Radiosynthesis and First Preclinical Evaluation of the Novel
Wang C; Hu Z; Ding F; Zhao H; Du F; Lv C; Li L; Huang G; Liu J
Front Chem; 2022; 10():939160. PubMed ID: 35991604
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and Preliminary Evaluation of
Ma H; Li F; Shen G; Cai H; Liu W; Lan T; Yang Y; Yang J; Liao J; Liu N
Mol Pharm; 2021 Nov; 18(11):4179-4187. PubMed ID: 34591481
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, Preclinical Evaluation, and a Pilot Clinical PET Imaging Study of
Zhao L; Niu B; Fang J; Pang Y; Li S; Xie C; Sun L; Zhang X; Guo Z; Lin Q; Chen H
J Nucl Med; 2022 Jun; 63(6):862-868. PubMed ID: 34556528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
